We are live on ! Find out more
NC

Noked Capital Portfolio holdings

AUM $946K
1-Year Est. Return 17.1%
This Fund
S&P 500
This Quarter Est. Return
-14.26%
1 Year Est. Return
-17.1%
3 Year Est. Return
+197.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$119M
AUM Growth
–
Cap. Flow
+$135M
Cap. Flow %
112.79%
Top 10 Hldgs %
74.79%
Holding
57
New
57
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$29.5M
2
ITRN icon
Ituran Location and Control
ITRN
+$15.7M
3
CSTE icon
Caesarstone
CSTE
+$12.8M
4
SEDG icon
SolarEdge
SEDG
+$9.2M
5
MLNX
Mellanox Technologies, Ltd.
MLNX
+$8.26M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 33.1%
2 Healthcare 25.26%
3 Industrials 12.43%
4 Energy 6.89%
5 Financials 5.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MERC icon
51
Mercer International
MERC
$44.8M
$282K 0.24%
+27,000
New +$375K
PLAB icon
52
Photronics
PLAB
$1.85B
$281K 0.24%
+29,000
New +$279K
KFRC icon
53
Kforce
KFRC
$1.03B
$278K 0.23%
+9,000
New +$290K
TRS icon
54
TriMas Corp
TRS
$1.45B
$273K 0.23%
+10,000
New +$285K
PRFT
55
DELISTED
Perficient Inc
PRFT
$267K 0.22%
+12,000
New +$294K
HOFT icon
56
Hooker Furnishings Corp
HOFT
$160M
$263K 0.22%
+10,000
New +$298K
RICK icon
57
RCI Hospitality Holdings
RICK
$192M
$239K 0.2%
+10,696
New +$268K
1 2
3

Similar funds

MC
Manteio Capital Jersey City, New Jersey $1.05M AUM
GAM
GVO Asset Management Zug, Switzerland $1.07M AUM 24.36% 1-Year Est. Return
NP
Nimble Partners San Francisco, California $556K AUM 61.7% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
IVAV
Index Venture Associates V St. Helier, Channel Islands, Jersey $1.46M AUM 88.05% 1-Year Est. Return
VM
Value Monitoring Menlo Park, California $1.5M AUM 13.21% 1-Year Est. Return
SC
Saban Cheryl $334K AUM 44.88% 1-Year Est. Return
CL
CRV LLC Palo Alto, California $1.56M AUM 87.36% 1-Year Est. Return

Noked Capital's Q4 2018 Portfolio in Review

Q4 2018 is the first quarter with a 13F filing on record for Noked Capital, which disclosed 57 positions worth $119M. Its ten largest holdings account for 75% of the portfolio.

Its largest position is Teva Pharmaceuticals: 1,439,275 shares worth $22.2M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, followed by Healthcare and Industrials.

  • Noked Capital's largest Q4 2018 buy was Teva Pharmaceuticals: 1,439,275 shares worth $22.2M.
  • Noked Capital's ten largest holdings make up 75% of its $119M portfolio in Q4 2018.
  • Noked Capital disclosed 57 positions in Q4 2018, its first 13F filing on record.

Based on Noked Capital's 13F filing for Q4 2018, filed 12 Feb 2019.